Orbimed Advisors Llc - 31 Dec 2024 SCHEDULE 13G Report for ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT)

Filing Manager: Orbimed Advisors Llc
Reporting Manager: ORBIMED CAPITAL LLC
Security: ADC Therapeutics SA Common Shares, par value CHF 0.08 per share
Symbol: ADCT
Shares outstanding: 95.5M shares
Disclosed Ownership: 3.44M shares
Ownership: 3.6%
Form type: SCHEDULE 13G
Filing time: 14 Feb 2025, 16:35:24
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	2.6%	2.53M	0	2.53M	/s/ Carl L. Gordon	Carl L. Gordon/Member
ORBIMED CAPITAL LLC	3.6%	3.44M	3.44M	0	/s/ Carl L. Gordon	Carl L. Gordon/Member